Evidence map›Paper›PMID 31209011›Full record

ArticleAntimicrobial agents and chemotherapy2019

Small-Molecule Morphogenesis Modulators Enhance the Ability of 14-Helical β-Peptides To Prevent Candida albicans Biofilm Formation.

Angélica de L Rodríguez López, Myung-Ryul Lee, Nathan B Wang, Kaitlin K Dunn, Hiram Sanchez, Namrata Raman, David R Andes, David M Lynn, Sean P Palecek

Erratum issuedOpen access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Repositioning Antimicrobial Peptides Against WHO-Priority Fungi.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  3. Article
  4. Various Biomimetics, Including Peptides as Antifungals.Biomimetics (Basel, Switzerland) · 2023
    Review
  5. Review
  6. The Antimicrobial Peptide AMP-17 Derived fromAntibiotics (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Angélica de L Rodríguez LópezDepartment of Materials Science and Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Myung-Ryul LeeDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Nathan B WangDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Kaitlin K DunnDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Hiram SanchezDepartment of Medicine and Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Namrata RamanDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
David R AndesDepartment of Medicine and Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
David M LynnDepartment of Materials Science and Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA dlynn@engr.wisc.edu sppalecek@wisc.edu.
Sean P PalecekDepartment of Materials Science and Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA dlynn@engr.wisc.edu sppalecek@wisc.edu.
University of Wisconsin–Madison · US

Funding

WATER DISTRIB:PHYSICAL PROPERT:PIZZA &LMPS MOZZARELLA CHEESES:EARLY STAGE MATURP41RR002301 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN LUTE · 1985 to 2011
$13.0M
Chemistry-Biology Interface Training ProgramT32GM008505 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BLACKWELL, HELEN E. · 1993 to 2023
$9.8M
Vesicle-mediated drug resistance of Candida albicans biofilmR01AI073289 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ANDES, DAVID R, MITCHELL, AARON P · 2008 to 2025
$7.9M
Prevention of C. Albicans Biofilms by Beta-Peptide Release From Thin FilmsR01AI092225 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2011 to 2015
$1.8M
Prevention of Candida biofilms by localized delivery of aurein analoguesR33AI127442 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2019 to 2021
$1.4M
Prevention of Candida biofilms by localized delivery of aurein analoguesR21AI127442 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2017 to 2018
$421k
NCRR NIH HHS P41 RR002301NIAID NIH HHS R01 AI073289NIAID NIH HHS R01 AI092225NIAID NIH HHS R21 AI127442NIAID NIH HHS R33 AI127442NIGMS NIH HHS T32 GM008505
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsAntimicrobial Cationic PeptidesBiofilmsCandida albicansHyphaePentanolsPeptidesAntifungal AgentsAntimicrobial Cationic Peptidesisopentyl alcoholPentanolsPeptidesantimicrobial peptide mimeticbiofilmCandida albicansmorphogenesis

Identifiers

PMID31209011
PMCPMC6709471
OpenAlexW2949315405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.